| 摘要 |
PROBLEM TO BE SOLVED: To provide a monoaminergic nerve-activating agent scarcely exhibiting side effects. SOLUTION: This monoaminergic nerve-activating agent contains ipidacrine (9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinoline), its hydrate, or its pharmaceutically acceptable salt, preferably, hydrated ipidacrine hydrochloride, as an active ingredient. The hydrated ipidacrine hydrochloride or the like usefully acts as a prophylactic or remedy for various symptoms relating to senile dementia, depression, anxiety, Parkinson's disease, mental retardation, anergasia, dysthymia, hypersomnia including narcolepsy, hyperkinetic syndrome, central nervous system syndrome including intelligence impairment, and pathologic conditions including obesity.
|
